Molecular Partners AG - ADR
MOLN
Get informed when a big investor buys or sells
+ FollowMarket Cap$154.17M
Close$
$2.67
35.2% downside
Current Fair Value
35.2% downsideOvervalued by 35.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $154.17 Million |
|---|---|
| Enterprise Value | $78.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.65 |
| Beta | 0.71 |
| Outstanding Shares | 37,502,552 |
Return
| Return on Equity | -90.34% |
|---|---|
| Return on Assets | -70.55% |
| Return on Invested Capital | -78.88% |
Valuation & Multiples
| P/E Ratio | -1.96 |
|---|---|
| PEG | -23969.68 |
| Price to Sales | - |
| Price to Book Ratio | 4.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.27 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 24, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.60%▲ 0.00% |
|---|---|
| Total Invested | $14.24M▼ 8.48% |
| Investors Holding | 4▼ 2.00% |
ESG Score
No data
About Molecular Partners AG
CEO: Patrick Amstutz